Show/Hide Menu
Hide/Show Apps
Logout
Türkçe
Türkçe
Search
Search
Login
Login
OpenMETU
OpenMETU
About
About
Open Science Policy
Open Science Policy
Open Access Guideline
Open Access Guideline
Postgraduate Thesis Guideline
Postgraduate Thesis Guideline
Communities & Collections
Communities & Collections
Help
Help
Frequently Asked Questions
Frequently Asked Questions
Guides
Guides
Thesis submission
Thesis submission
MS without thesis term project submission
MS without thesis term project submission
Publication submission with DOI
Publication submission with DOI
Publication submission
Publication submission
Supporting Information
Supporting Information
General Information
General Information
Copyright, Embargo and License
Copyright, Embargo and License
Contact us
Contact us
In-Depth Method for the Characterization of Glycosylation in Manufactured Recombinant Monoclonal Antibody Drugs
Download
index.pdf
Date
2014-06-17
Author
Song, Ting
Özcan Kabasakal, Süreyya
Becker, Alicia
Lebrilla, Carlito B.
Metadata
Show full item record
This work is licensed under a
Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License
.
Item Usage Stats
216
views
102
downloads
Cite This
The glycosylation in recombinant monoclonal antibody (rMab) drugs is a major concern in the biopharmaceutical industry as it impacts the drugs' many attributes. Characterization is important but complicated by the intricate structures, microheterogeneity, and the limitations of current tools for structural analysis. In this study, we developed a liquid chromatography-mass spectrometry (LC-MS) N-glycan library based on eight commercial rMab drugs. A library of over 70 structures was developed for the rapid characterization of rMab. N-Glycans were separated on a porous graphitized carbon (PGC) column incorporated on a chip and then analyzed by an electrospray ionization hybrid quadrupole time-of-flight (ESI-Q-TOF) MS. The retention time and accurate mass for each N-glycan were recorded in the library. The complete structures were obtained through exoglycosidase sequencing. The results showed that most of the N-glycans between different antibodies are nearly the same with different abundances. The utility of this library enables one to identify structures in a rapid manner by matching LC retention times and accurate masses.
Subject Keywords
Analytical Chemistry
URI
https://hdl.handle.net/11511/38819
Journal
ANALYTICAL CHEMISTRY
DOI
https://doi.org/10.1021/ac501102t
Collections
Department of Chemistry, Article
Suggestions
OpenMETU
Core
High-Throughput Screening and Quantitation of Target Compounds in Biofluids by Coated Blade Spray-Mass Spectrometry
Tascon, Marcos; Gomez-Rios, German Augusto; Reyes-Garces, Nathaly; Poole, Justen; Boyacı, Ezel; Pawliszyn, Janusz (American Chemical Society (ACS), 2017-08-15)
Most contemporary methods of screening and quantitating controlled substances and therapeutic drugs in biofluids typically require laborious, time-consuming, and expensive analytical workflows. In recent years, our group has worked toward developing microextraction (mu e)-mass spectrometry (MS) technologies that merge all of the tedious steps of the classical methods into a simple, efficient, and low-cost methodology. Unquestionably, the automation of these technologies allows for faster sample throughput, ...
Technologies for glycomic characterization of biopharmaceutical erythropoietins
Hua, Serenus; Oh, Myung Jin; Özcan Kabasakal, Süreyya; Seo, Young Suk; Grimm, Rudolf; An, Hyun Joo (Elsevier BV, 2015-05-01)
Glycosylation is one of the most critical factors affecting the quality, the safety and the potency of recombinant erythropoietin. Small changes during production can significantly affect glycosylation, and so the potency, of recombinant erythropoietin. Due to patent expirations, we expect biosimilar erythropoietins to play an increasing role in healthcare in coming years. Governmental regulatory agencies and biopharmaceutical companies therefore have an urgent need for reliable methods that can accurately ...
Equilibrium studies on the back extraction of lactic acid from organic phase
Karaburun, Füsun; Gürkan, Türker; Department of Chemical Engineering (2004)
Lactic acid is a fermentation-derived organic acid used in a wide range of industries, such as food processing and pharmaceuticals. Its market is expected to expand due to the worldwide concern for the environment, as it is an essential feedstock for biodegradable polymers. However, fermentation product is a very dilute, multicomponent aqueous solution. Subsequent separation, purification and concentration of organic acids is difficult because of high affinity of the acids for water. Reactive extraction is ...
Novel Pt(II) complexes containing pyrrole oxime, synthesis, characterization and DNA binding studies
Altunöz Erdoğan, Deniz; Ozalp-Yaman, Seniz (Elsevier BV, 2014-05-05)
Since the discovery of anticancer activity and subsequent clinical success of cisplatin (cis-[PtCl2(NH3)(2)]), platinum-based compounds have since been widely synthesized and studied as potential chemotherapeutic agents. In this sense, three novel nuclease active Pt(II) complexes with general formula; [Pt(NH3)CI(L)] (1), [Pt(L)(2)] (2), and K[PtCl2(L)] (3) in which L is 1-H-pyrrole-2-carbaldehyde oxime were synthesized. Characterization of complexes was performed by elemental analysis, FT-IR, H-1 NMR and ma...
Investigation of Compositional, Structural, and Dynamical Changes of Pentylenetetrazol-Induced Seizures on a Rat Brain by FT-IR Spectroscopy
Turker, Sevgi; İLBAY, GÜL; Severcan, Mete; Severcan, Feride (American Chemical Society (ACS), 2014-02-04)
To accomplish the appropriate treatment strategies of epilepsy action mechanisms underlying epileptic seizures should be lightened. The identification of epileptic seizure-induced alterations on the brain related to their pathologies may provide information for its action mechanism. Therefore, the current study determined molecular consequences of seizures induced by pentylenetetrazol (PTZ), which is a widely used convulsant agent, on rat brain. The rats were administered subconvulsant (25 mg/kg) and convul...
Citation Formats
IEEE
ACM
APA
CHICAGO
MLA
BibTeX
T. Song, S. Özcan Kabasakal, A. Becker, and C. B. Lebrilla, “In-Depth Method for the Characterization of Glycosylation in Manufactured Recombinant Monoclonal Antibody Drugs,”
ANALYTICAL CHEMISTRY
, pp. 5661–5666, 2014, Accessed: 00, 2020. [Online]. Available: https://hdl.handle.net/11511/38819.